CRYO-CELL International, Inc.
General ticker "CCEL" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $67.6M
CRYO-CELL International, Inc. follows the US Stock Market performance with the rate: 24.9%.
Estimated limits based on current volatility of 1.4%: low 7.64$, high 7.85$
Factors to consider:
- Company pays dividends: last record date 2024-11-15, amount 0.25$ (Y12.94%)
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-11-30 to 2025-11-29
- 2023-11-30 to 2024-11-29 estimated range: [3.47$, 6.63$]
- 2024-11-29 to 2025-11-29 estimated range: [4.36$, 7.96$]
Financial Metrics affecting the CCEL estimates:
- Negative: Operating profit margin, % of -28.19 <= 1.03
- Positive: 0.10 < Non-GAAP EPS, $ of 0.46
- Negative: negative Net income
- Positive: Operating cash flow per share per price, % of 22.10 > 12.76
- Positive: -3.48 < Investing cash flow per share, $ of -0.98
- Positive: 3.85 < Industry operating cash flow per share per price (median), % of 5.56
Short-term CCEL quotes
Long-term CCEL plot with estimates
Financial data
| YTD | 2021-11-30 | 2022-11-30 | 2023-11-30 |
|---|---|---|---|
| Operating Revenue | $28.88MM | $30.34MM | $31.34MM |
| Operating Expenses | $24.87MM | $26.31MM | $43.65MM |
| Operating Income | $4.02MM | $4.02MM | $-12.30MM |
| Non-Operating Income | $-1.41MM | $-0.71MM | $-1.06MM |
| Interest Expense | $1.38MM | $1.52MM | $1.24MM |
| R&D Expense | $0.05MM | $0.38MM | $1.17MM |
| Income(Loss) | $2.61MM | $3.32MM | $-13.36MM |
| Taxes | $0.53MM | $0.55MM | $-3.84MM |
| Profit(Loss) | $2.08MM | $2.77MM | $-9.52MM |
| Stockholders Equity | $4.18MM | $-1.52MM | $-11.03MM |
| Inventory | $0.92MM | $0.85MM | $0.77MM |
| Assets | $60.66MM | $64.89MM | $61.22MM |
| Operating Cash Flow | $7.93MM | $8.57MM | $8.92MM |
| Capital expenditure | $6.95MM | $17.17MM | $7.64MM |
| Investing Cash Flow | $-6.95MM | $-15.28MM | $-8.14MM |
| Financing Cash Flow | $-3.07MM | $0.15MM | $-2.07MM |
| Earnings Per Share* | $0.26 | $0.33 | $-1.14 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.